Cytokine gene polymorphisms in sarcoidosis.
M Vasakova1, M Sterclova, L Kolesar
1Department of Respiratory Diseases, 1st Medical School Charles University and University Thomayer Hospital Prague, Czech Republic. martina.vasakova@ftn.cz
Summary
Genetic variations in interleukin-10 (IL-10) influence sarcoidosis risk. Specific IL-10 genotypes and haplotypes were more common in sarcoidosis patients, suggesting a role for immune dysregulation in this disease.
Area of Science:
- Immunogenetics
- Molecular Medicine
- Autoimmune Diseases
Background:
- Sarcoidosis is an inflammatory disease characterized by granuloma formation, primarily affecting the lungs and lymph nodes.
- The underlying immunopathogenesis is thought to involve dysregulated immune responses to various antigens, potentially influenced by genetic factors.
- This study investigates the role of cytokine gene polymorphisms in sarcoidosis.
Purpose of the Study:
- To investigate the association between cytokine gene polymorphisms and sarcoidosis.
- To compare the frequency of specific genetic variations in patients with sarcoidosis and healthy controls.
- To explore the potential link between genetic predisposition and immune dysregulation in sarcoidosis.
Main Methods:
- Genotyping of polymorphisms in promoter and translated regions of key cytokine genes, including IL-1alpha, IL-1beta, IL-1R, IL-1RA, IL-2, IL-4, IL-6, IL-10, IL-12, TNF-alpha, IFN-gamma, TGF-beta, and IL-4RA.
- Analysis of 31 sarcoidosis patients and a control group of healthy volunteers.
- Statistical comparison of genotype and haplotype frequencies between the patient and control groups.
Main Results:
- A statistically significant higher frequency of CC homozygosity at positions (-819) and (-592) of the IL-10 gene was observed in the sarcoidosis group compared to healthy controls.
- The IL-10 (-1082)(-819)(-592) ACC haplotype 2 was more prevalent in sarcoidosis patients, whereas the ATA haplotype was more common in controls.
- These findings suggest a genetic predisposition related to IL-10 expression levels.
Conclusions:
- The study supports the hypothesis of a genetically determined immune regulation imbalance in sarcoidosis.
- Specific high-producer IL-10 genotypes (CC at -819 and -592) and the intermediate-producer ACC haplotype 2 are associated with sarcoidosis.
- These genetic factors may contribute to the disregulation of cell-mediated immune responses against unknown antigens in sarcoidosis.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...